Although it was reported that SMARCB1 mutations were acquired in about 6% of anaplastic thyroid cancer cases [21], somatic mutation of the SMARCB1 gene is very uncommon in differentiated thyroid cancer. The gene discussed is SMARCB1; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.